Pimavanserin, developed and marketed by Xinchem Corporation, is a novel antipsychotic medication primarily used for the treatment of Parkinson’s disease psychosis. As a leading manufacturer and supplier based in China, Xinchem Corporation prides itself on high-quality pharmaceutical production, ensuring rigorous standards and reliable supply chains. The company’s state-of-the-art factory leverages advanced technology and strict quality controls to produce Pimavanserin, meeting both domestic and international demands. Known for its selective serotonin inverse agonist properties, Pimavanserin offers an effective treatment option with a favorable safety profile. Xinchem Corporation’s commitment as a trusted China manufacturer and supplier guarantees consistent product quality and timely delivery, supporting healthcare providers worldwide in managing neuropsychiatric conditions. With Xinchem Corporation’s expertise and robust manufacturing capabilities, Pimavanserin stands out as a vital therapeutic agent in modern medicine.